What Are the Side Effects of Semaglutide? A Look at NCBI Data
•
4 min read
According to pooled data from the Semaglutide Treatment Effect in People With Obesity (STEP) trials, gastrointestinal adverse events were significantly more common with semaglutide compared to placebo, affecting nearly 73% of participants at the 2.4 mg dose. A deep dive into what are the side effects of semaglutide NCBI? reveals that while most are mild and manageable, some rare but serious risks exist, necessitating informed patient care and monitoring.
